DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lucentis (Ranibizumab) - News

 
 



News related to Lucentis (Ranibizumab) and/or conditions it is approved for

Study finds ethnic differences in effect of age-related macular degeneration on visual function
Source: Eye Health / Blindness News From Medical News Today [2017.04.04]
In study that included Chinese, Malay, and Indian participants, researchers found that among those with age-related macular degeneration (AMD) there were ethnic differences in visual function, such...

Repeated eye injections for age-related macular degeneration associated with increased risk for glaucoma surgery
Source: Eye Health / Blindness News From Medical News Today [2017.03.20]
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study...

Macular Degeneration
Source: MedicineNet Eyeglasses, Sunglasses, and Magnifiers Specialty [2016.05.06]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 12:00:00 AM
Last Editorial Review: 5/6/2016 12:00:00 AM

Switching to a low-glycemic diet may stop age-related eye disease, study suggests
Source: Eye Health / Blindness News From Medical News Today [2017.05.18]
A study in mice finds that development of age-related macular degeneration (AMD) could be arrested by switching from a high-glycemic diet (starches as are found in white bread) to a low-glycemic...

Unproven stem cell 'therapy' blinds three patients at Florida clinic
Source: Eye Health / Blindness News From Medical News Today [2017.03.17]
Three people with macular degeneration were blinded after undergoing an unproven stem cell treatment that was touted as a clinical trial in 2015 at a clinic in Florida.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017